The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma

Leukemia and Lymphoma

Volumn 44, Issue 1, 2003, Pages 123-125

  Guppy, A E ^a   Tebbutt, N C ^a   Norman, A ^a   Cunningham, D ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Lymphoma; Relapse; Surveillance CT scans; Tumour

Indexed keywords

BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; FOLLOW UP; HUMAN; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYMPTOMATOLOGY; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; RECURRENCE; REMISSION INDUCTION; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037236406     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000040323     Document Type: Article

References (12)

1. Armitage, J.O. (1993) "Treatment of non-Hodgkin's lymphoma", N. Engl. J. Med. 328(14), 1023-1030.
2. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der, L.H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y. and Harousseau, J.L. (1995) "Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma", N. Engl. J. Med. 333(23), 1540-1545.
3. Petersen, F.B., Appelbaum, F.R., Hill, R., Fisher, L.D., Bigelow, C.L., Sanders, J.E., Sullivan, K.M., Bensinger, W.I., Witherspoon, R.P. and Storb, R. (1990) "Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle", J. Clin. Oncol. 8(4), 638-647.
4. Fisher, R.I., Gaynor, E.R., Dahlberg, S., Oken, M.M., Grogan, T.M., Mize, E.M., Glick, J.H., Coltman, Jr., C.A. and Miller, T.P. (1993) "Comparison of standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma", N. Engl. J. Med. 328(14), 1002-1006.
5. Kaplan, E.L. and Meier, P. (1958) "Non-parametric estimation from incomplete observations", J. Am. Stat. Assoc. 53, 457-481.
6. Shipp, M.A. (1994) "Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?", Blood 83(5), 1165-1173.
7. Blay, J., Gomez, F., Sebban, C., Bachelot, T., Biron, P., Guglielmi, C., Hagenbeek, A., Somers, R., Chauvin, F. and Philip, T. (1998) "The International Prognostic Index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial. Parma Group", Blood 92(10), 3562-3568.
8. Weeks, J.C., Yeap, B.Y, Canellos, G.P. and Shipp, M.A. (1991) "Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission", J. Clin. Oncol 9(7), 1196-1203.
9. Radford, J.A., Eardley, A., Woodman, C. and Crowther, D. (1997) "Follow up policy after treatment for Hodgkin's disease: too many clinic visits and routine tests? A review of hospital records", BMJ 314(7077), 343-346.
10. Elis, A., Blickstein, D., Klein, O., Eliav-Ronen, R., Manor, Y. and Lishner, M. (2002) "Detection of relapse in non-Hodgkin's lymphoma: role of routine follow-up studies", Am. J. Hematol. 69(1), 41-44.
11. Jerusalem, G., Beguin, Y., Fassotte, M.F., Najjar, F., Paulus, P., Rigo, P. and Fillet, G. (1999) "Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging", Blood 94(2), 429-433.
12. Spaepen, K., Stroobants, S., Dupont, P., Van Steenweghen, S., Thomas, J., Vandenberghe, P., Vanuytsel, L., Bormans, G., Balzarini, J., Wolf-Peeters, C., Mortelmans, L. and Verhoef, G. (2001) "Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?", J. Clin. Oncol. 19(2), 414-419.